Quadria Capital
Quadria Capital
Quadria Capital
  • About
    • Overview
    • Our Focus
    • Team
  • Approach
    • Our Strategy
    • Our Differentiators
  • Portfolio
  • Impact and ESG
    • Impact Thesis
    • Our Framework
    • Guiding Principles
    • Case Studies
  • Publications
  • Careers
  • Contact

Quadria Capital consortium acquires stake in ‘Concord Biotech’

July 5, 2016

Quadria Capital, through its Singapore based SPV, Helix Investments Pvt. Limited has successfully concluded an investment deal in Concord Biotech Ltd.

VIEW NEWS ARTICLE
← View All Publications
Previous Reading
Quadria Capital’s Amit Varma on attractive segments in healthcare for new VC fund
Next Reading
Quadria Capital led consortium acquires stake in Concord Biotech

Quadria Capital

© Quadria Capital

Terms  |  Privacy

ABOUT

Overview

Our Focus

Team

APPROACH

Our Strategy

Our Differentiators

PORTFOLIO

Our Portfolio

IMPACT and ESG

Impact Thesis

Our Framework

Guiding Principles

Case Studies

Queries or Concerns

STAY CONNECTED

Publications

Careers

Contact

Subscribe

LinkedInLinkedIn

  • About
    • Overview
    • Our Focus
    • Team
  • Approach
    • Our Strategy
    • Our Differentiators
  • Portfolio
  • Impact and ESG
    • Impact Thesis
    • Our Framework
    • Guiding Principles
    • Case Studies
  • Publications
  • Careers
  • Contact

What are you looking for?